期刊文献+

螺内酯在犬心房颤动模型中对心房结构重构及电重构的影响 被引量:3

Effect of spironolactone on atrial structural remodeling and electrical remodeling in the canine atrial fibrillation model
原文传递
导出
摘要 目的:观察螺内酯在犬心房颤动(房颤)模型中对心房结构重构和电重构的影响。方法:24只健康犬随机分为对照组(普通喂食)、房颤组(快速起搏+普通喂食)和螺内酯组(快速起搏+螺内酯灌胃),采用心房快速起搏建立犬房颤的动物模型。建模成功后,取左心房肌组织测定基质金属蛋白酶(MMP)-9、MMP组织抑制物(TIMP)-1以及miRNA-101水平,比较各组间以上指标的差异。结果:与对照组比较,房颤组和螺内酯组MMP-9、MMP-9/TIMP-1均显著升高(均P<0.01),房颤组TIMP-1降低(P<0.01),螺内酯组TIMP-1升高(P<0.01);与房颤组比较,螺内酯组MMP-9表达水平降低(P<0.05),TIMP-1表达水平升高(P<0.05),MMP-9/TIMP-1的比值降低(P<0.05)。房颤组miRNA-101较对照组及螺内酯组明显下调(P<0.05),而螺内酯组与对照组间未见显著差异。结论:快速心房起搏诱导房颤后可使心房肌出现电重构和结构重构,螺内酯干预可以上调miRNA-101,升高MMPs,降低TIMP,改善心房肌结构重构和电重构,从而起到预防和治疗房颤的作用。 Objective:To observe the effect of spironolactone on atrial structure remodeling and electrical remodeling in the canine atrial fibrillation model.Method:Twenty-four healthy adult dogs were selected and ran- domly divided into control group(n=8,normal feeding),atrial fibrillation group(n=8,pacemaker implantation and normal feeding)and spironolactone group(n=8,pacemaker implantation and spironolactone intervention). Pacemaker implantation and rapid atrial pacing were adopted to establish the canine atrial fibrillation model.After a week the model was successfully established and left atrial tissue was taken to determination the level of matrix metalloproteinase(MMP)-9,tissue inhibitor-1of MMP(TIMP-1)and miRNA-101.Then we compared the above indexes between different groups.Result:Compared to control group,the level of MMP-9,MMP-9/TIMP-1ratio were significantly higher in atrial fibrillation group and spironolactone group(both P〈0.01),the level of TIMP- 1was significantly lower in atrial fibrillation group(P〈0.01)and was significantly higher in spironolactone group (P〈0.01);Compared to atrial fibrillation group,the level of MMP-9in spironolactone group was lower(P 0.05),the expression of TIMP-1was higher(P〈0.05),the ratio of MMP-9/TIMP-1declined (P〈0.05). Quantitative analysis showed that the miRNA-101in atrial fibrillation group obviously down-regulated compared with in control group and spironolactone group(both P〈0.05),and it didn′t show statistically significant differ- ence between spironolactone group and control group.Conclusion:Atrial fibrillation caused by rapid atrial pacing could lead atrial structural remodeling and electrical remodeling.Spironolactone intervention could up-regulate miRNA-101,decrease MMP-9levels and elevate TIMP-1levels,which play a role of prevention and treatment for atrial fibrillation.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2013年第6期466-469,共4页 Journal of Clinical Cardiology
关键词 心房颤动 螺内酯 miRNA-101 电重构 结构重构 atrial fibrillation spironolactone miRNA-101 electrical remodeling structural remodeling
  • 相关文献

参考文献3

二级参考文献34

  • 1柯丹,许春萱,林亚洲,张建成,陈林,林立芳,胡锡衷.心房颤动患者心房纤维化分子基础的临床研究[J].中华心血管病杂志,2005,33(5):459-463. 被引量:25
  • 2SPINALE F G, COKER M L, BOND B R, et al. Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic target[J]. Cardiovasc Res, 2000,46 : 225-238.
  • 3DAHLOF B, DEVEREUX R B, KJELDSEN S E, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol[J]. Lancet, 2002,359 : 995-1003.
  • 4MAGGIONI A P, LATINI R, CARSON P E, et al. Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT) [J]. Am Heart J, 2005,149 : 548-557.
  • 5GRANGER C B, MCMURRAY J, YUSUF S, et at. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors : the CHARM-Alternative trial[J]. Lancet,2003, 362:772-776.
  • 6HOIT B D, TAKEISHI Y, COX M J, et al. Remode- ling of the left atrium inpacing-induced atrial cardiomyop- athy[J]. Mol Cell Bioehem, 2002,238 :145-150.
  • 7CHEN Y H,XU W J,BENDAHHOU S,et al.KCNQ1 gain-of-function mutation in familial atrial fibrillation[J].Science,2003,299:251-254.
  • 8YANG Y,XIA M,JIN Q,et al.Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillation[J].Am J Hum Genet,2004,75:899-905.
  • 9XIA M,JIN Q,BENDAHHAOU S,et al.A kir2.1 gain-of-function mutation underlies familial atrial fibrillation[J].Biochem Biophys Res Commum,2005,332:1012-1019.
  • 10HONG K,PIPER D R,DIAZ-VLDECANTOS A,et al.De novo KCNQ1 mutation responsible for atrial fibrillation and short QT syndrome:clinical findings and diagnostic-therapeutic implications[J].Eur Heart J,2006,27:2440-2447.

共引文献35

同被引文献22

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部